Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NBIX | C | Neurocrine Biosciences, Inc. | 0.52 | |
DCTH | C | Delcath Systems, Inc. | -0.91 | |
LDOS | C | Leidos Holdings, Inc. | 0.50 | |
VCNX | C | Vaccinex, Inc. | 0.56 | |
QURE | D | uniQure N.V. | -1.11 | |
ATRA | D | Atara Biotherapeutics, Inc. | 8.11 | |
ALNY | D | Alnylam Pharmaceuticals, Inc. | -0.77 | |
TCON | D | TRACON Pharmaceuticals, Inc. | -7.56 | |
FGEN | D | FibroGen, Inc | 2.12 | |
MEIP | D | MEI Pharma, Inc. | -1.07 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Cancer
Medicine
Biopharmaceutical
Biotechnology
Sarcoma
Solid Tumors
Acute Myeloid Leukemia
Breast Cancer
Clinical Trial
Drugs
Monoclonal Antibody
Ovarian Cancer
Pain
Treatment Of Breast Cancer
Tumor
Advanced Solid Tumors
Age Related Macular Degeneration
Analgesics
Anti Cancer Therapies
Antibody
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | D | Simplify Health Care ETF | 14.21 | |
BBH | D | Market Vectors Biotech ETF | 8.73 | |
IDNA | F | iShares Genomics Immunology and Healthcare ETF | 7.66 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 7.16 | |
IBBQ | F | Invesco Nasdaq Biotechnology ETF | 6.83 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Medicine
Monoclonal Antibodies
Biology
Biotechnology
Sarcoma
Antibodies
Bone
Breast Cancer
Clinical Research
Colorectal Cancer
Drugs
Human Monoclonal Antibodies
Immunology
Infectious Diseases
Life Sciences
Macular Degeneration
Treatment Of Breast Cancer
Adenosine
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles